Case Studies

Pharmaceutical Company Explores Market Opportunities in Breast Cancer

Posted by | Fuld & Company , Fuld & Company

Background & Challenge

A pharmaceutical client in the oncology market was in need of effectively tracking the developmental programs of the metastatic breast cancer market.


  • Created a clinical development pipeline of all early to late-stage therapies, providing insights into the clinical trial design, target indication, and primary and secondary endpoints.
  • Prioritized key competitors in the market, and created data readouts, filing, and market launch timelines based on primary and secondary research.
  • For selected on-market therapy, determined commercialization activity, and strategy.
  • Attended ASCO and SABC on behalf of the client.
  • Updated the client by e-mail of any new key findings and market updates.
  • Provided the client with quarterly detailed findings using graphics and charts in easy to understand formats.

Result & Benefits

Client received regular and timely updates on developments and changes in its competitors’ programs using its corporate templates. Fuld identified competitor product delays allowing the client to significantly revise its corporate earnings forecast. Fuld detailed specific marketing strategies that allowed clients to counter strategize. Fuld also identified potential partnering and in-licensing opportunities.

[gravityform id=”48″ title=”true” description=”true”]

Tags: , , , , ,

Related Resources

Read More

Sustainable innovation in the polymer industry

Delivering sustainable innovation How we helped a leading industrial polymer manufacturer cut 1.5 years off its R&D timeline… and win […]

Read More

Leveraging Machine Learning in Customer Sentiment Analysis

In a highly competitive market, staying ahead of customer expectations is critical for any manufacturer. A leading US plumbing fixture […]

Read More

Healthcare and Pharma Competitive Intelligence Dashboard

A US-based healthcare company wanted to explore its options for a clinical drug development strategy that would minimize its time […]

Subscribe to our mailing list for our latest updates: